Wealth Quarterback’s Novo Nordisk NVO Stock Holding History

Wealth Quarterback’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$751K	Buy	19,797 +1,171	+6%	+$54K	0.23%	69
2026 Q2	$893K	Buy	18,626 +519	+3%	+$22.3K	0.28%	62
2026 Q1	$665K	Buy	18,107 +2,298	+15%	+$109K	0.26%	70
2025 Q4	$804K	Sell	15,809 -4,605	-23%	-$235K	0.29%	61
2025 Q3	$1.13M	Buy	20,414 +598	+3%	+$35K	0.44%	46
2025 Q2	$1.37M	Buy	19,816 +3,795	+24%	+$258K	0.65%	36
2025 Q1	$1.11M	Buy	16,021 +3,660	+30%	+$302K	0.63%	35
2024 Q4	$1.06M	Buy	12,361 +5,174	+72%	+$560K	0.5%	42
2024 Q3	$856K	Buy	+7,187	New	+$958K	0.45%	50
2021 Q3	$45K	Buy	924 +264	+40%	+$12.8K	0.03%	254
2021 Q2	$28K	Buy	+660	New	+$25.6K	0.02%	304
2020 Q2	–	Sell	-644	Closed	-$19.4K	–	543
2020 Q1	$19.4K	Sell	644 -100	-13%	-$2.98K	0.02%	342
2019 Q4	$21.5K	Buy	+744	New	+$20.6K	0.02%	339

Other funds holding NVO

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors New York $1.81B AUM 23.74% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

Wealth Quarterback's NVO Position: Q3 2026 in Review

Wealth Quarterback increased its Novo Nordisk (NVO) stake by 6.3% in Q3 2026, buying an estimated $54K and bringing the position to 19,797 shares worth $751K. The position accounts for 0.23% of the portfolio, ranked #69.

Wealth Quarterback first reported a position in NVO in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.37M in Q2 2025. 344 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Wealth Quarterback held 19,797 shares of Novo Nordisk worth $751K as of Q3 2026.
Wealth Quarterback bought 1,171 Novo Nordisk shares in Q3 2026, an estimated $54K.
Novo Nordisk made up 0.23% of Wealth Quarterback's portfolio in Q3 2026, its #69 holding.
Wealth Quarterback first reported a position in Novo Nordisk in Q4 2019 and has held it in 13 quarters since.
Wealth Quarterback's Novo Nordisk position peaked at $1.37M in Q2 2025.
344 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Wealth Quarterback's 13F filing for Q3 2026, filed 20 Oct 2026.